Fatma Taş Arslan

Fatma Taş Arslan

Auto-generated profile, based on publicly available information

Fatma Taş Arslan

Selcuk Universitesi

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

14 November 2018 in Scandinavian Journal of Caring Sciences
Verified
Journal Article
Closed access
PDF file
SASevinc Akkoyun
Sevinc Akkoyun
FAFatma Tas Arslan
Fatma Tas Arslan

11 October 2021 in European Journal of Cancer Care
Verified
Journal Article
Closed access
PDF file
HKHazal Ozdemir Koyu
Hazal Ozdemir Koyu
FAFatma Tas Arslan
Fatma Tas Arslan

30 March 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
FAFatma Tas Arslan
Fatma Tas Arslan
ZBZumrut Basbakkal
Zumrut Basbakkal
MKMehmet Kantar
Mehmet Kantar
Quality of Life and Chemotherapy-related Symptoms of Turkish Cancer Children Undergoing Chemotherapy Children;cancer;chemotherapy;symptoms;quality of life;Turkey; This cross-sectional and descriptive study was designed to determine symptoms emerging due to chemotherapy treatment and their effects on children's quality of life. The research was carried out between February 2008 and February 2009 at the pediatric oncology clinics in four hospitals, focusing on 93 patients receiving chemotherapy. A survey form, the Pediatric Quality of Life Inventory (PedsQL 4.0) and the Memorial Symptom Assessment Scale (MSAS) were used as data collection tools. Chi-square and Student t tests were performed for data analysis. Some 51.6% of the children were aged 13-15 years old, and 51.8% were boys and 50.5% were diagnosed as having solid tumors. There were significant relations between: antimetabolite chemotherapeutics and feeling irritable and worrying (p=0.001, p=0.030); vinkoalkaloid and numbness/tingling in hands/feet (p=0.043); antracyclines and lack of energy and skin changes (p=0.021, p=0.004); and corticosteroids and lack of appetite, nausea and sadness (p=0.008, p=0.009, p=0.009). Several symptoms such as feeling sad, worrying and feeling irritable caused a significant decrease in the total domain of quality of life scores (p=0.034, p=0.012, p=0.010, respectively). Chemotherapeutic drugs can cause symptoms that can seriously affect quality of life in children.